New drug combo tested to fight liver scarring from hepatitis b
Disease control
Not yet recruiting
This study is testing whether adding a weekly injection (peginterferon) to standard daily antiviral pills works better than the pills alone for people with stable liver scarring caused by hepatitis B. It will enroll 30 adults with compensated cirrhosis to see if the combination i…
Phase: NA • Sponsor: Xiamen Humanity Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC